Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc. more
Time Frame | MGRX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.6% | 0.67% | 0.49% |
1-Month Return | 4.22% | 0.26% | 5.96% |
3-Month Return | -39.01% | -6.21% | 9.35% |
6-Month Return | -52.95% | 1.69% | 14.4% |
1-Year Return | -76.03% | 11.41% | 32.23% |
3-Year Return | -95.88% | 12.87% | 33.15% |
Dec '21 | Dec '22 | Dec '23 | ||||
---|---|---|---|---|---|---|
Total Revenue | - | 8.94K | 731.49K | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | ||
Cost of Revenue | - | 4.09K | 299.99K | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | ||
Gross Profit | - | 4.85K | 431.50K | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | ||
Gross Margin | - | 54.26% | 58.99% | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":91.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | ||
Operating Expenses | 17.52K | 2.00M | 9.65M | [{"date":"2021-12-31","value":0.18,"profit":true},{"date":"2022-12-31","value":20.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | ||
Operating Income | (17.52K) | (1.99M) | (9.22M) | [{"date":"2021-12-31","value":-1752000,"profit":false},{"date":"2022-12-31","value":-199158200,"profit":false},{"date":"2023-12-31","value":-921889000,"profit":false}] | ||
Total Non-Operating Income/Expense | - | (12.95K) | 11.15K | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-116.15,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | ||
Pre-Tax Income | (17.70K) | (2.00M) | (9.21M) | [{"date":"2021-12-31","value":-1770100,"profit":false},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-921241700,"profit":false}] | ||
Income Taxes | (70.08K) | (224.62K) | 1.00 | [{"date":"2021-12-31","value":-7008000,"profit":false},{"date":"2022-12-31","value":-22462200,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | ||
Income After Taxes | - | (1.77M) | (9.21M) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-177343300,"profit":false},{"date":"2023-12-31","value":-921241800,"profit":false}] | ||
Income From Continuous Operations | - | (2.00M) | (7.32M) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-731802500,"profit":false}] | ||
Income From Discontinued Operations | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | ||
Net Income | (17.70K) | (2.00M) | (9.21M) | [{"date":"2021-12-31","value":-1770100,"profit":false},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-921241700,"profit":false}] | ||
EPS (Diluted) | - | (0.08) | (5.77) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8,"profit":false},{"date":"2023-12-31","value":-577.32,"profit":false}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
MGRX | |
---|---|
Cash Ratio | 0.05 |
Current Ratio | 0.07 |
Quick Ratio | 0.07 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MGRX | |
---|---|
ROA (LTM) | -57.51% |
ROE (LTM) | -108.44% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MGRX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.09 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.91 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MGRX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 7.32 |
P/B | 0.47 |
Price/FCF | NM |
EV/R | 8.66 |
EV/Ebitda | NM |
Mangoceuticals, Inc. Common Stock (MGRX) share price today is $2.47
Yes, Indians can buy shares of Mangoceuticals, Inc. Common Stock (MGRX) on Vested. To buy Mangoceuticals, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MGRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Mangoceuticals, Inc. Common Stock (MGRX) via the Vested app. You can start investing in Mangoceuticals, Inc. Common Stock (MGRX) with a minimum investment of $1.
You can invest in shares of Mangoceuticals, Inc. Common Stock (MGRX) via Vested in three simple steps:
The 52-week high price of Mangoceuticals, Inc. Common Stock (MGRX) is $13.35. The 52-week low price of Mangoceuticals, Inc. Common Stock (MGRX) is $2.1.
The price-to-earnings (P/E) ratio of Mangoceuticals, Inc. Common Stock (MGRX) is
The price-to-book (P/B) ratio of Mangoceuticals, Inc. Common Stock (MGRX) is 0.47
The dividend yield of Mangoceuticals, Inc. Common Stock (MGRX) is 0.00%
The market capitalization of Mangoceuticals, Inc. Common Stock (MGRX) is $6.34M
The stock symbol (or ticker) of Mangoceuticals, Inc. Common Stock is MGRX